Idenix Pharmaceuticals LLC;Universite de Montpellier;Centre National de la Recherche Scientifique;L'UNIVERSITE MONTPELLIER II;Universita Degli Studi Di Cagliari;IDENIX (CAYMAN) LIMITED
2' and/or 3' prodrugs of l', 2', 3' or 4'-branchednucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of